The molecular and cellular mechanisms behind SGMS2-linked osteoporosis are not fully understood, but it is believed that the onset of the disease is a result of improperly targeted bulk SM production rather than a diminished capacity to synthesize SM. The gene discussed is SGMS2; the disease is osteoporosis.